Culme-SeymourDr Emily Culme-Seymour
External Strategy Manager, Gene Therapy, Rare Diseases Unit
Emily is a scientist working in the gene therapy team in GSK’s Rare Diseases Unit, looking at developing external relationships and partnerships in the field, as well as providing scientific guidance and input to the internal gene therapy strategy and developmental programmes. She has a background in Chemistry and Biochemical Engineering, looking at engineering growth substrates for pluripotent stem cell bioprocessing during her PhD. Emily is also a Director of the London Regenerative Medicine Network (LRMN), and previously represented the LRMN on a number of UK and EU scientific consortium projects looking at cell therapy technologies and business modelling. She currently sits on the International Society for Cell Therapy’s Executive Committee as Global Treasurer and is co-chair of their Early Stage Professionals Committee, is a member of the UK BioIndustry Association’s Cell and Gene Therapy Advisory Committee, sits on the American Society for Gene and Cell Therapy’s International Committee, is a member of the US Alliance for Regenerative Medicine Gene and Gene-Modified Cell Therapy Section, and the European and British Societies for Gene and Cell Therapy.
DEBATING MATTERS HISTORY
Thursday 27 June:
Oxfordshire Championship at Oxford Union, in partnership with Magdalen College School and Oxford Festival of Arts
Friday 5 July:
North East Championship at Durham Sixth Form Centre
Find a list of all our previous championship events here.
SUPPORT DEBATING MATTERS
Bernie Whelan, our DM coordinator, is raising money for Debating Matters.
To stage one of our Championships for six to 12 teams costs £6,000. Find out more on Bernie’s
Wonderful fundraising page.